Lifshitz & Miller Law Firm Announces Investigation of Caesars Acquisition Company, Imperial Holdings, Inc., Peerless Systems Corporation, Roka Bioscience, Inc., RCS Capital Corporation and Uroplasty, Inc.

NEW YORK, Dec. 30, 2014 /PRNewswire/ -- 

Caesars Acquisition Company

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Caesars Acquisition Company ("CACQ") to Caesars Entertainment Corporation in an all-stock transaction whereby each outstanding share of CACQ class A common stock will be exchanged for 0.664 share of Caesars Entertainment common stock.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Imperial Holdings, Inc.

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of Imperial Holdings, Inc. ("IFT").  Specifically, on November 3, 2014, IFT announced that its Board of Directors has adopted a by-law that requires a shareholder, before filing a lawsuit against IFT, its board of directors or its officers, to obtain consents of shareholders beneficially owning at least three (3) percent of IFT's common shares.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Peerless Systems Corporation

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Peerless Systems Corporation  ("PRLS") to Mobius Acquisition, LLC in a cash transaction valued at $7.00 per share.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Roka Bioscience, Inc.  

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of Roka Bioscience, Inc. ("ROKA").  Specifically, on July 17, 2014, Roka conducted its IPO at $12 per share.  On November 6, 2014, Atlas announced a surprise loss of ($0.64) per share in the third quarter of 2014 and that it had not placed any additional instruments since June 30, 2014.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

RCS Capital Corporation

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of RCS Capital Corporation ("RCAP").  Specifically, on October 29, 2014, American Realty Capital Properties, Inc. ("ARCP") announced that its Audit Committee believes that ARCP intentionally did not correct certain amounts related to its non-controlling interests in AFFO for the three months ended March 31, 2014 and, as a result, overstated AFFO.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Uroplasty, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Uroplasty, Inc.  ("UPI") to Vision-Sciences, Inc. in an all-stock transaction whereby UPI shareholders will receive 3.6331 shares of Vision-Sciences, Inc. common stock for each share of Uroplasty stock they own.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-caesars-acquisition-company-imperial-holdings-inc-peerless-systems-corporation-roka-bioscience-inc-rcs-capital-corporation-and-uroplasty-inc-300014519.html

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com